Stock BRTL EVOME MEDICAL TECHNOLOGIES INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Evome Medical Technologies Inc.

Equities

BRTL

CA30053H1055

Advanced Medical Equipment & Technology

Market Closed - Toronto S.E.
Other stock markets
 03:41:52 2024-04-26 pm EDT 		5-day change 1st Jan Change
0.195 CAD -7.14% Intraday chart for Evome Medical Technologies Inc. -20.41% -7.14%
Apr. 16 Evome Medical Technologies Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Apr. 02 Riddell, Inc. acquired Simbex, LLC from Evome Medical Technologies Inc. for $3.6 million. CI

Valuation

Fiscal Period: December 2021 2022 2023 2024
Capitalization 1 29.53 24.78 16.46 15.38
Enterprise Value (EV) 1 29.53 24.78 16.46 15.38
P/E ratio -8 x -1.55 x -1 x -3.9 x
Yield - - - -
Capitalization / Revenue - 0.74 x 0.26 x 0.25 x
EV / Revenue - 0.74 x 0.26 x 0.25 x
EV / EBITDA - - 19.3 x 7.44 x
EV / FCF - - - -
FCF Yield - - - -
Price to Book - - - -
Nbr of stocks (in thousands) 46,146 55,063 78,370 78,890
Reference price 2 0.6400 0.4500 0.2100 0.1950
Announcement Date 4/30/21 4/3/23 4/1/24 -
1CAD in Million2CAD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2021 2022 2023 2024
Net sales 1 - 33.59 62.6 62.21
EBITDA 1 - - 0.8515 2.068
EBIT - - - -
Operating Margin - - - -
Earnings before Tax (EBT) - - - -
Net income 1 -2.667 - -15.6 -5.019
Net margin - - -24.92% -8.07%
EPS 2 -0.0800 -0.2900 -0.2100 -0.0500
Free Cash Flow - - - -
FCF margin - - - -
FCF Conversion (EBITDA) - - - -
FCF Conversion (Net income) - - - -
Dividend per Share - - - -
Announcement Date 4/30/21 4/3/23 4/1/24 -
1CAD in Million2CAD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period:
Estimates

Balance Sheet Analysis

Fiscal Period: December 2021 2022 2023 2024
Net Debt - - - -
Net Cash position - - - -
Leverage (Debt/EBITDA) - - - -
Free Cash Flow - - - -
ROE (net income / shareholders' equity) - - - -
ROA (Net income/ Total Assets) - - - -
Assets 1 - - - -
Book Value Per Share - - - -
Cash Flow per Share - - - -
Capex - - - -
Capex / Sales - - - -
Announcement Date 4/30/21 4/3/23 4/1/24 -
1CAD in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.195 CAD
Average target price
1.15 CAD
Spread / Average Target
+489.74%
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

1st Jan change Capi.
EVOME MEDICAL TECHNOLOGIES INC. Stock Evome Medical Technologies Inc.
-7.14% 11.24M
THERMO FISHER SCIENTIFIC Stock Thermo Fisher Scientific
+8.07% 219B
DANAHER CORPORATION Stock Danaher Corporation
+6.59% 183B
INTUITIVE SURGICAL, INC. Stock Intuitive Surgical, Inc.
+11.26% 133B
BOSTON SCIENTIFIC CORPORATION Stock Boston Scientific Corporation
+26.57% 108B
SIEMENS HEALTHINEERS AG Stock Siemens Healthineers AG
+0.65% 63.06B
EDWARDS LIFESCIENCES CORPORATION Stock Edwards Lifesciences Corporation
+13.35% 52.02B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. Stock Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
-0.62% 48.2B
AGILENT TECHNOLOGIES, INC. Stock Agilent Technologies, Inc.
-0.93% 40.37B
GE HEALTHCARE TECHNOLOGIES INC. Stock GE HealthCare Technologies Inc.
+11.54% 39.35B
Other Advanced Medical Equipment & Technology
  1. Stock Market
  2. Equities
  3. BRTL Stock
  4. Financials Evome Medical Technologies Inc.